Picture of NANOSONICS logo

NAN — NANOSONICS News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Australia's Nanosonics rises on U.S. FDA clearance for disinfection product

** Shares of Nanosonics NAN.AX rise as much as 11.8% to A$4.35, their highest level since June 16

** Stock set for best day since March 20

** Infection prevention company gets U.S. Food and Drug Administration (FDA) clearance for its latest generation of trophon technology, meant to be used as a disinfection system during ultrasound probes

** Clearance will allow co to launch trophon3 and trophon2 Plus in the United States, representing opportunity to install around 30,000 devices in total

** YTD, stock up 32.6%

(Reporting by Shruti Agarwal in Bengaluru)

((Shruti.Agarwal@thomsonreuters.com;))

Recent news on NANOSONICS

See all news